RESUMEN
BACKGROUND: Neutral lipid storage disease with myopathy (NLSD-M) is an autosomal recessive disease that manifests itself around the 3rd to 4th decade with chronic myopathy predominantly proximal in the shoulder girdle. Clinical myotonia is uncommon. We will report a rare case of association of pathogenic variants on PNPLA2 and CLCN1 genes with a mixed phenotype of NLSD-M and a subclinical form of Thomsen's congenital myotonia. CASE PRESENTATION: We describe a patient with chronic proximal myopathy, subtle clinical myotonia and electrical myotonia on electromyography (EMG). Serum laboratory analysis disclosure hyperCKemia (CK 1280 mg/dL). A blood smear analysis showed Jordan's anomaly, a hallmark of NLSD-M. A genetic panel was collected using next-generation sequencing (NGS) technique, which identified two pathogenic variants on genes supporting two different diagnosis: NLSD-M and Thomsen congenital myotonia, whose association has not been previously described. CONCLUSIONS: Although uncommon, it is important to remember the possibility of association of pathogenic variants to explain a specific neuromuscular disease phenotype. The use of a range of complementary methods, including myopathy genetic panels, may be essential to diagnostic definition in such cases.
Asunto(s)
Enfermedades Musculares , Miotonía Congénita , Miotonía , Humanos , Aciltransferasas/genética , Canales de Cloruro/genética , Lipasa/genética , Enfermedades Musculares/diagnóstico , Enfermedades Musculares/genética , Enfermedades Musculares/patología , Mutación/genética , Miotonía/genética , Miotonía Congénita/diagnóstico , Miotonía Congénita/genéticaRESUMEN
We reported a 32-year-old man who was a sporadic case of myotonic syndrome with muscle stiffness or transient weakness of limbs upon initiating movements after rest. On examination, he showed painless myotonia with warm-up phenomenon, Hercules-like hypertrophic musculature and myotonic discharges in EMG. The clinical findings resembled to those of Becker disease rather than Thomsen disease. But electrodiagnosis suggested sodium channel myotonia instead of chloride channelopathy. Genetic testing detected a novel missense mutation (p.V1166A) in the SCN4A gene but not in the CLCN1 gene. Transient weakness upon initiating movements is usually observed in Becker disease but rare in Thomsen disease, which is not reported in sodium channel myotonia so far. He was probably the first case of sodium channel myotonia with transient weakness upon initiating movements, which was confirmed by 10â Hz repetitive nerve stimulation test as depolarization block.
Asunto(s)
Electrodiagnóstico , Movimiento/fisiología , Debilidad Muscular/diagnóstico , Miotonía Congénita/diagnóstico , Adulto , Electromiografía , Pruebas Genéticas , Humanos , Masculino , Debilidad Muscular/complicaciones , Debilidad Muscular/fisiopatología , Mutación Missense , Miotonía Congénita/complicaciones , Miotonía Congénita/genética , Miotonía Congénita/patología , Miotonía Congénita/fisiopatología , Canal de Sodio Activado por Voltaje NAV1.4/genética , Estimulación Eléctrica Transcutánea del NervioRESUMEN
La miotonía congénita es la forma más común de miotonía no distrófica. Esta miopatía está causada por mutaciones en el gen CLCN1, codificante del principal canal de iones cloruro del músculo esquelético (ClC-1); la alteración de la función de este canal, regulado por voltaje, da lugar al fenómeno de miotonía. La enfermedad se puede heredar con un tipo de herencia dominante (enfermedad de Thomsen) o recesiva (enfermedad de Becker o miotonía congénita generalizada). El fenotipo clínico de ambas formas de la enfermedad es similar aunque la forma recesiva se caracteriza por una mayor gravedad de los síntomas. El diagnóstico clínico de miotonía congénita debe sospecharse cuando encontramos en un paciente episodios de rigidez muscular (miotonía), remisión o alivio de la rigidez con el ejercicio (fenómeno warm-up), miotonía clínica, un patrón electromiográfico característico y/o historia familiar. El diagnóstico molecular de miotonía congénita consiste en el análisis por secuenciación del gen CLCN1 (AU)
Myotonia congenita is the most common form of non-dystrophic myotonia. This myopathy is caused by mutations in the CLCN1 gene, encoding the main skeletal muscle chloride ion channel (ClC-1). Altering the function of this voltage-gated channel, leads to the phenomenon of myotonia. The disease can be inherited with a dominant (Thomsen disease) or recessive type (Becker disease or congenital generalised myotonia). The clinical phenotype of both forms of the disease is similar, although the recessive form is characterised by more severe symptoms. The clinical diagnosis of congenital myotonia should be suspected in a patient who presents with episodes of muscle stiffness (myotonia), remission or relief from stiffness with exercise (warm-up phenomenon), and a characteristic electromyography pattern, and/or family history. Sequencing the CLCN1 gene is the present approach for molecular diagnosis of myotonia congenita (AU)
Asunto(s)
Humanos , Masculino , Femenino , Miotonía Congénita/diagnóstico , Miotonía Congénita/genética , Miositis/complicaciones , Miositis/diagnóstico , Mutagénesis/genética , Biología Molecular/métodos , Diagnóstico Diferencial , Diagnóstico Clínico/diagnóstico , Diagnóstico Clínico/tendencias , Trastornos Miotónicos/diagnóstico , Trastornos Miotónicos/genética , Distrofia Muscular de Duchenne/complicaciones , Distrofia Muscular de Duchenne/diagnósticoRESUMEN
At least 50 disease-causing mutations in the skeletal muscle voltage-gated chloride channel gene (CLCN1), almost all of which originate from Caucasian families, have been identified. We investigated a Japanese family with Thomsen's myotonia congenita that included 16 affected individuals (8 men and 8 women) through five generations. Polymerase chain reaction (PCR)-single-strand conformation polymorphism (SSCP) screening of 11 members showed an aberrant conformer in exon 13 of CLCN1 complementary DNA (cDNA) in 8 affected and 1 unaffected members. By sequence analysis, we identified a C-to-A transition at nucleotide position 1438, resulting in a substitution of proline for threonine at amino acid position 480 (P480T), the same position of the original mutation (P480L) in Thomsen's disease. The P480T mutation was novel and absent in 100 normal controls. Seven of the 8 affected individuals were heterozygous; another, from affected parents, was homozygous. Clinically, myotonia in the homozygous patient was more severe than that in heterozygous patients, probably due to the gene dosage effect. On a long-train nerve-stimulation test at a rate of 3 Hz, M-wave responses in the homozygous patient showed marked decrement followed by recovery. In contrast, the heterozygous patients showed just a slight decrement or no changes, and none of 2 patients with myotonic muscular dystrophy or 2 normal controls revealed any decrement. Thus, the long-train nerve-stimulation test at a low stimulus frequency may be a useful tool to assess the disease-severity/genotype relationship in myotonia congenita.
Asunto(s)
Canales de Cloruro/genética , Salud de la Familia , Miotonía Congénita/genética , Mutación Puntual , Adulto , Análisis Mutacional de ADN , Electromiografía , Femenino , Heterocigoto , Homocigoto , Humanos , Japón , Masculino , Persona de Mediana Edad , Miotonía Congénita/diagnóstico , Linaje , Nervio CubitalRESUMEN
Three men, aged 36, 16 and 66 years, had suffered for several years from muscular weakness; after a low serum potassium level had been established, supplementary examination revealed hypokalaemic periodic paralysis. A woman aged 25 had suffered since youth from muscular stiffness on sudden movements; she suffered from hereditary myotonia of the recessive type (Becker's disease). Both rare skeletal muscle ion channel diseases are characterized by the fact that the variable clinical expression complicates making the diagnosis. Since the causal mutations are known, genetic analysis is an essential step in confirming the diagnosis. Additional EMG procedures may be of diagnostic value, even in cases that cannot be clarified genetically.
Asunto(s)
Parálisis Periódica Hipopotasémica/diagnóstico , Rigidez Muscular/metabolismo , Debilidad Muscular/metabolismo , Músculo Esquelético/metabolismo , Miotonía Congénita/diagnóstico , Mutación Puntual , Canales de Potasio/genética , Potasio/metabolismo , Adolescente , Adulto , Anciano , Cromosomas Humanos Par 1/genética , Análisis Mutacional de ADN , Diagnóstico Diferencial , Electromiografía , Femenino , Humanos , Parálisis Periódica Hipopotasémica/genética , Parálisis Periódica Hipopotasémica/fisiopatología , Masculino , Rigidez Muscular/genética , Debilidad Muscular/genética , Miotonía Congénita/genética , Miotonía Congénita/fisiopatología , Mutación Puntual/genética , Potasio/sangre , Potasio/uso terapéuticoRESUMEN
A point mutation (D136G) predicting the substitution of glycine for aspartate in position 136 of the human muscle Cl- channel (hClC-1) causes recessive generalized myotonia. Heterologous expression of a recombinant D136G produces functional Cl- channels with profound alterations in voltage-dependent gating, without concomitant changes in pore properties. The mutant exhibits slowly activating current upon hyperpolarization, in contrast to wild-type channels, which display time-dependent current decay (deactivation) at negative membrane potentials. Steady-state activation of D136G depends upon the transmembrane Cl- gradient, reaching zero at voltages positive to the Cl- reversal potential in physiological Cl- distribution. This explains the reduced sarcolemmal Cl- conductance that causes myotonia. The functional disturbances exhibited by D136G may stem from a defect in the ClC-1 voltage sensor.
Asunto(s)
Ácido Aspártico/fisiología , Canales de Cloruro/química , Activación del Canal Iónico/fisiología , Proteínas Musculares/química , Músculo Esquelético/metabolismo , Miotonía Congénita/genética , Mutación Puntual , Potenciales de Acción , Animales , Secuencia de Bases , Línea Celular Transformada , Canales de Cloruro/genética , Canales de Cloruro/metabolismo , ADN Complementario/genética , Humanos , Riñón , Datos de Secuencia Molecular , Proteínas Musculares/genética , Proteínas Musculares/metabolismo , Mutagénesis Sitio-Dirigida , Miotonía Congénita/fisiopatología , Oocitos , Reacción en Cadena de la Polimerasa , Conformación Proteica , Proteínas Recombinantes de Fusión/metabolismo , Sarcolema/metabolismo , Relación Estructura-Actividad , Transfección , Xenopus laevisRESUMEN
Voltage-gated ClC chloride channels play important roles in cell volume regulation, control of muscle excitability, and probably transepithelial transport. ClC channels can be functionally expressed without other subunits, but it is unknown whether they function as monomers. We now exploit the properties of human mutations in the muscle chloride channel, ClC-1, to explore its multimeric structure. This is based on analysis of the dominant negative effects of ClC-1 mutations causing myotonia congenita (MC, Thomsen's disease), including a newly identified mutation (P480L) in Thomsen's own family. In a co-expression assay, Thomsen's mutation dramatically inhibits normal ClC-1 function. A mutation found in Canadian MC families (G230E) has a less pronounced dominant negative effect, which can be explained by functional WT/G230E heterooligomeric channels with altered kinetics and selectivity. Analysis of both mutants shows independently that ClC-1 functions as a homooligomer with most likely four subunits.
Asunto(s)
Canales de Cloruro/química , Genes Dominantes , Mutación , Miotonía Congénita/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Línea Celular , Canales de Cloruro/genética , Clonación Molecular , ADN Complementario , Femenino , Humanos , Masculino , Datos de Secuencia Molecular , Linaje , Conformación Proteica , Homología de Secuencia de AminoácidoRESUMEN
Autosomal recessive generalized myotonia (Becker's disease) (GM) and autosomal dominant myotonia congenita (Thomsen's disease) (MC) are characterized by skeletal muscle stiffness that is a result of muscle membrane hyperexcitability. For both diseases, alterations in muscle chloride or sodium currents or both have been observed. A complementary DNA for a human skeletal muscle chloride channel (CLC-1) was cloned, physically localized on chromosome 7, and linked to the T cell receptor beta (TCRB) locus. Tight linkage of these two loci to GM and MC was found in German families. An unusual restriction site in the CLC-1 locus in two GM families identified a mutation associated with that disease, a phenylalanine-to-cysteine substitution in putative transmembrane domain D8. This suggests that different mutations in CLC-1 may cause dominant or recessive myotonia.